Stem cell therapies for thalassemia
ISBT Education. Hongeng S. Nov 27, 2017; 203508 Topic: Stem cell transplantation
Suradej Hongeng
Suradej Hongeng
This content is exclusively available for members.

You may become an ISBT member here.
Learning Objectives
Discussion Forum (0)
Rate & Comment (0)
After viewing this presentation the participant will be able to:

- Evaluate past and current trials of stem cell and gene therapy for thalassemia patients
- Discuss how to improve current protocols to reduce the dose of conditioning regiments
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies